equitybuy

SQQQ · ProShares UltraPro Short QQQ

Trust-weighted public proof page for SQQQ. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
40 / 100
Current score
0.64
Thesis calls
3
Active decisions
2

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Andrei Jikhyoutubeopen

Source argues index providers (NASDAQ 100, FTSE/Russell) are changing rules (e.g., public float requirements) to pull large private companies into major indexes, forcing 401(k)/passive funds to buy “overpriced” IPO shares, creating an exit/liquidity event for insiders. Mentions SpaceX and xAI as examples, but provides no verifiable IPO timeline or concrete, tradable setup beyond a broad ‘passive flows buy IPOs’ narrative.

Mentioned: Jun 5, 2026, 5:15 PM EDTConviction: 27 / 100
Source: Your Money Is About To Buy The Biggest IPOs In History
Casual Financeyoutubeopen

The post argues that stocks can rise during war/geopolitical stress when positioning and market structure dominate the headline narrative. It describes large hedge fund short exposure to macro ETFs such as SPY and QQQ, CTA/systematic strategies flipping from short to long as trend improved, margin-covering dynamics, and dealer hedging from call buying creating a short/gamma squeeze. It also notes crude prices falling sharply, suggesting de-escalation or reduced supply-risk premium. The core take

Mentioned: May 4, 2026, 11:00 AM EDTConviction: 57 / 100
Source: if war bad... why stocks go up?
InTheMoneyyoutubeopen

Personal update from the author about being hospitalized for autoimmune encephalitis flare and receiving IVIG; includes a brief market comment noting a “red morning” but only a “tiny dip” in “CuteDQ” and encourages staying calm (implicit dip-buy / hold Nasdaq exposure).

Mentioned: Feb 17, 2026, 11:57 AM ESTConviction: 28 / 100
Source: Autoimmune Encephalitis Round 2: Electric Boogaloo

Current stance

Recommendationbuy
Authors3
Active decisions2
Latest price$65.57

Investment decisions

SQQQ
research_buy

SQQQ
watch

SQQQ
risk_review

SQQQ
risk_review

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.